CX3CL1 Signaling in the Tumor Microenvironment

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Fractalkine (CX3CL1) is a chemokine with a single receptor, CX3CR1, mediating diverse cellular effects.
• Its function varies from adhesion molecule to chemotactic cytokine, influencing immune cell survival and retention.
• The CX3CL1:CX3CR1 axis is implicated in inflammatory disorders and cancer immunity.

Purpose of the Study:

• To review the structure, function, and biology of CX3CL1.
• To address the diverse biological effects of CX3CL1 in the immune system and tumor microenvironment.
• To explore the potential of the CX3CL1 pathway as a therapeutic target in cancer.

Main Methods:

• Literature review of studies on CX3CL1 and CX3CR1.
• Analysis of CX3CL1's role in inflammatory and anti-viral/anti-tumor immunity.
• Examination of conflicting reports on CX3CL1's pro-tumorigenic and anti-tumorigenic functions.

Main Results:

• CX3CL1 exhibits context-dependent roles, acting as an adhesion molecule or chemoattractant.
• It plays a key role in maintaining effector memory cytotoxic T cells, crucial for anti-viral and anti-tumor immunity.
• CX3CL1 is reported as a TIL-recruiting chemokine and positive prognostic factor in some cancers, yet also linked to pro-tumorigenic and pro-metastatic effects in others.

Conclusions:

• The CX3CL1:CX3CR1 pathway presents a complex therapeutic target due to its dual roles in inflammation and immunity.
• Further mechanistic studies are required to fully elucidate CX3CL1's multifaceted functions in cancer.
• Appreciating all CX3CL1 interactions is vital for its potential as a cancer therapeutic target.